Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Lee, D; Wang, L; Dong, P; Tran, T; Copolov, D; Lim, AT
   Progesterone modulation of D5 receptor expression in hypothalamic ANP neurons, the role of estrogen
   MOLECULAR PSYCHIATRY
   
   D. Lee et al., "Progesterone modulation of D5 receptor expression in hypothalamic ANP neurons, the role of estrogen", MOL PSYCHI, 6(1), 2001, pp. 112-117
2. Wood, SJ; Velakoulis, D; Smith, DJ; Bond, D; Stuart, GW; McGorry, PD; Brewer, WJ; Bridle, N; Eritaia, J; Desmond, P; Singh, B; Copolov, D; Pantelis, C
   A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia
   SCHIZOPHRENIA RESEARCH
   
   S.J. Wood et al., "A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia", SCHIZOPHR R, 52(1-2), 2001, pp. 37-46
3. Dean, B; Sundram, S; Bradbury, R; Scarr, E; Copolov, D
   Studies on [H-3]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated withschizophrenia and cannabis use
   NEUROSCIENCE
   
   B. Dean et al., "Studies on [H-3]CP-55940 binding in the human central nervous system: Regional specific changes in density of cannabinoid-1 receptors associated withschizophrenia and cannabis use", NEUROSCIENC, 103(1), 2001, pp. 9-15
4. Dean, B; Pavey, G; McLeod, M; Opeskin, K; Keks, N; Copolov, D
   A change in the density of [H-3]flumazenil, but not [H-3]muscimol binding,in Brodmann's Area 9 from subjects with bipolar disorder
   JOURNAL OF AFFECTIVE DISORDERS
   
   B. Dean et al., "A change in the density of [H-3]flumazenil, but not [H-3]muscimol binding,in Brodmann's Area 9 from subjects with bipolar disorder", J AFFECT D, 66(2-3), 2001, pp. 147-158
5. Velakoulis, D; Stuart, GW; Wood, SJ; Smith, DJ; Brewer, WJ; Desmond, P; Singh, B; Copolov, D; Pantelis, C
   Selective bilateral hippocampal volume loss in chronic schizophrenia
   BIOLOGICAL PSYCHIATRY
   
   D. Velakoulis et al., "Selective bilateral hippocampal volume loss in chronic schizophrenia", BIOL PSYCHI, 50(7), 2001, pp. 531-539
6. Bell, R; McLaren, A; Copolov, D
   How reliable are reported plasma clozapine levels?
   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
   
   R. Bell et al., "How reliable are reported plasma clozapine levels?", AUST NZ J P, 35(4), 2001, pp. 468-473
7. Silberstein, RB; Line, P; Pipingas, A; Copolov, D; Harris, P
   Steady-state visually evoked potential topography during the continuous performance task in normal controls and schizophrenia
   CLINICAL NEUROPHYSIOLOGY
   
   R.B. Silberstein et al., "Steady-state visually evoked potential topography during the continuous performance task in normal controls and schizophrenia", CLIN NEU, 111(5), 2000, pp. 850-857
8. Lee, D; Huang, W; Wang, L; Copolov, D; Lim, AT
   Glucocorticoid modulation of dopamine mediated effects on hypothalamic atrial natriuretic factor neurons
   MOLECULAR PSYCHIATRY
   
   D. Lee et al., "Glucocorticoid modulation of dopamine mediated effects on hypothalamic atrial natriuretic factor neurons", MOL PSYCHI, 5(3), 2000, pp. 332-336
9. Pralong, D; Tomaskovic-Crook, E; Opeskin, K; Copolov, D; Dean, B
   Serotonin(2A) receptors are reduced in the planum temporale from subjects with schizophrenia
   SCHIZOPHRENIA RESEARCH
   
   D. Pralong et al., "Serotonin(2A) receptors are reduced in the planum temporale from subjects with schizophrenia", SCHIZOPHR R, 44(1), 2000, pp. 35-45
10. Mallard, C; Loeliger, M; Copolov, D; Rees, S
    Reduced number of neurons in the hippocampus and the cerebellum in the postnatal guinea-pig following intrauterine growth-restriction
    NEUROSCIENCE
    
    C. Mallard et al., "Reduced number of neurons in the hippocampus and the cerebellum in the postnatal guinea-pig following intrauterine growth-restriction", NEUROSCIENC, 100(2), 2000, pp. 327-333
11. Copolov, D; Velakoulis, D; McGorry, P; Mallard, C; Yung, A; Rees, S; Jackson, G; Rehn, A; Brewer, W; Pantelis, C
    Neurobiological findings in early phase schizophrenia
    BRAIN RESEARCH REVIEWS
    
    D. Copolov et al., "Neurobiological findings in early phase schizophrenia", BRAIN RES R, 31(2-3), 2000, pp. 157-165
12. Copolov, D; Crook, J
    Biological markers and schizophrenia
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    
    D. Copolov e J. Crook, "Biological markers and schizophrenia", AUST NZ J P, 34, 2000, pp. S108-S112
13. Velakoulis, D; McGorry, P; Copolov, D; Pantelis, C
    Hippocampal and superior temporal gyrus volume in first-episode schizophrenia - In reply
    ARCHIVES OF GENERAL PSYCHIATRY
    
    D. Velakoulis et al., "Hippocampal and superior temporal gyrus volume in first-episode schizophrenia - In reply", ARCH G PSYC, 57(6), 2000, pp. 618-619
14. Copolov, D
    Menders of the mind: A history of the Royal Australian and New Zealand College of Psychiatrists, 1946-1996
    AMERICAN JOURNAL OF PSYCHIATRY
    
    D. Copolov, "Menders of the mind: A history of the Royal Australian and New Zealand College of Psychiatrists, 1946-1996", AM J PSYCHI, 157(2), 2000, pp. 299-299
15. Mallard, EC; Rehn, A; Rees, S; Tolcos, M; Copolov, D
    Ventriculomegaly and reduced hippocampal volume following intrauterine growth-restriction: implications for the aetiology of schizophrenia
    SCHIZOPHRENIA RESEARCH
    
    E.C. Mallard et al., "Ventriculomegaly and reduced hippocampal volume following intrauterine growth-restriction: implications for the aetiology of schizophrenia", SCHIZOPHR R, 40(1), 1999, pp. 11-21
16. Torrey, F; Jablensky, A; Pearlson, G; Knable, M; Adityanjee; Ingraham, L; Africa, B; De Lisi, L; Wildenauer, D; Copolov, D; Buka, S; Murray, R; Stevens, J; Jones, P; Rund, B; Goldberg, T; Gallhofer, B; Falkai, P; Tsuang, M; Schroder, J; Bogerts, B; Friedman, L; Bogerts, B; Lawson, B; Bachus, S; Post, R; Haas, G
    Stanley Foundation Satellite Symposium, Santa Fe, New Mexico, Saturday, April 17, 1999
    SCHIZOPHRENIA RESEARCH
    
    F. Torrey et al., "Stanley Foundation Satellite Symposium, Santa Fe, New Mexico, Saturday, April 17, 1999", SCHIZOPHR R, 39(2), 1999, pp. 159-163
17. Lee, D; Dong, P; Copolov, D; Lim, AT
    D-5 dopamine receptors mediate estrogen-induced stimulation of hypothalamic atrial natriuretic factor neurons
    MOLECULAR ENDOCRINOLOGY
    
    D. Lee et al., "D-5 dopamine receptors mediate estrogen-induced stimulation of hypothalamic atrial natriuretic factor neurons", MOL ENDOCR, 13(2), 1999, pp. 344-352
18. Dean, B; Scarr, E; Bradbury, R; Copolov, D
    Decreased hippocampal (CA3) NMDA receptors in schizophrenia
    SYNAPSE
    
    B. Dean et al., "Decreased hippocampal (CA3) NMDA receptors in schizophrenia", SYNAPSE, 32(1), 1999, pp. 67-69
19. Dean, B; Tomaskovic-Crook, E; Opeskin, K; Keks, N; Copolov, D
    No change in the density of the serotonin(1A) receptor, the serotonin(4) receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia
    NEUROCHEMISTRY INTERNATIONAL
    
    B. Dean et al., "No change in the density of the serotonin(1A) receptor, the serotonin(4) receptor or the serotonin transporter in the dorsolateral prefrontal cortex from subjects with schizophrenia", NEUROCHEM I, 34(2), 1999, pp. 109-115
20. O'Neill, M; Brewer, W; Thornley, C; Copolov, D; Warne, G; Sinclair, A; Forrest, S; Williamson, R
    Kallmann syndrome gene (KAL-X) is not mutated in schizophrenia
    AMERICAN JOURNAL OF MEDICAL GENETICS
    
    M. O'Neill et al., "Kallmann syndrome gene (KAL-X) is not mutated in schizophrenia", AM J MED G, 88(1), 1999, pp. 34-37
21. Crook, JM; Dean, B; Pavey, G; Copolov, D
    The binding of [H-3]AF-DX 384 is reduced in the Caudate-Putamen of subjects with schizophrenia
    LIFE SCIENCES
    
    J.M. Crook et al., "The binding of [H-3]AF-DX 384 is reduced in the Caudate-Putamen of subjects with schizophrenia", LIFE SCI, 64(19), 1999, pp. 1761-1771
22. Copolov, D
    Hubris and humility in the life of the schizophrenia researcher
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
    
    D. Copolov, "Hubris and humility in the life of the schizophrenia researcher", AUST NZ J P, 33(3), 1999, pp. 299-306
23. Velakoulis, D; Pantelis, C; McGorry, PD; Dudgeon, P; Brewer, W; Cook, M; Desmond, P; Bridle, N; Tierney, P; Murrie, V; Singh, B; Copolov, D
    Hippocampal volume in first-episode psychoses and chronic schizophrenia - A high-resolution magnetic resonance imaging study
    ARCHIVES OF GENERAL PSYCHIATRY
    
    D. Velakoulis et al., "Hippocampal volume in first-episode psychoses and chronic schizophrenia - A high-resolution magnetic resonance imaging study", ARCH G PSYC, 56(2), 1999, pp. 133-141
24. NAYLOR L; DEAN B; PEREIRA A; MACKINNON A; KOUZMENKO A; COPOLOV D
    NO ASSOCIATION BETWEEN THE SEROTONIN TRANSPORTER-LINKED PROMOTER REGION POLYMORPHISM AND EITHER SCHIZOPHRENIA OR DENSITY OF THE SEROTONIN TRANSPORTER IN HUMAN HIPPOCAMPUS
    Molecular medicine (Cambridge, Mass.)
    
    L. Naylor et al., "NO ASSOCIATION BETWEEN THE SEROTONIN TRANSPORTER-LINKED PROMOTER REGION POLYMORPHISM AND EITHER SCHIZOPHRENIA OR DENSITY OF THE SEROTONIN TRANSPORTER IN HUMAN HIPPOCAMPUS", Molecular medicine (Cambridge, Mass.), 4(10), 1998, pp. 671-674
25. Dean, B; Hayes, W; Hill, C; Copolov, D
    Decreased Serotonin(2A) receptors in Brodmann's area 9 from schizophrenic subjects - A pathological or pharmacological phenomenon?
    MOLECULAR AND CHEMICAL NEUROPATHOLOGY
    
    B. Dean et al., "Decreased Serotonin(2A) receptors in Brodmann's area 9 from schizophrenic subjects - A pathological or pharmacological phenomenon?", MOL CHEM NE, 34(2-3), 1998, pp. 133-145
26. BREWER W; FRANCEY S; YUNG A; VELAKOULIS D; ANDERSON V; MCGORRY P; SINGH B; COPOLOV D; PANTELIS C
    COGNITIVE AND OLFACTORY DEFICITS - COURSE FROM HIGH-RISK TO FIRST-EPISODE PSYCHOSIS
    Schizophrenia research
    
    W. Brewer et al., "COGNITIVE AND OLFACTORY DEFICITS - COURSE FROM HIGH-RISK TO FIRST-EPISODE PSYCHOSIS", Schizophrenia research, 29(1-2), 1998, pp. 54-55
27. BREWER W; VELAKOULIS D; ANDERSON V; LAMBERT J; MCGORRY P; SINGH B; COPOLOV D; PANTELIS C
    OLFACTORY ACUITY DEFICITS FOR THE ODOR OF SCHIZOPHRENIA IN CHRONIC AND FIRST-EPISODE PATIENTS
    Schizophrenia research
    
    W. Brewer et al., "OLFACTORY ACUITY DEFICITS FOR THE ODOR OF SCHIZOPHRENIA IN CHRONIC AND FIRST-EPISODE PATIENTS", Schizophrenia research, 29(1-2), 1998, pp. 55-55
28. VELAKOULIS D; PANTELIS C; MCGORRY P; YUNG A; BREWER WJ; BRIDLE N; TIERNEY P; LE T; DESMOND PM; SINGH B; COPOLOV D
    CAUDATE VOLUME CHANGES ACROSS 3 STAGES OF PSYCHOSIS
    Schizophrenia research
    
    D. Velakoulis et al., "CAUDATE VOLUME CHANGES ACROSS 3 STAGES OF PSYCHOSIS", Schizophrenia research, 29(1-2), 1998, pp. 80-80
29. VELAKOULIS D; PANTELIS C; STUART G; MCGORRY P; YUNG A; BREWER WJ; BRIDLE N; DESMOND PM; SINGH B; COPOLOV D
    THE SITE OF HIPPOCAMPAL VOLUME REDUCTION DIFFERS BETWEEN FIRST-EPISODE AND CHRONIC-SCHIZOPHRENIA
    Schizophrenia research
    
    D. Velakoulis et al., "THE SITE OF HIPPOCAMPAL VOLUME REDUCTION DIFFERS BETWEEN FIRST-EPISODE AND CHRONIC-SCHIZOPHRENIA", Schizophrenia research, 29(1-2), 1998, pp. 83-83
30. FARNBACHPRALONG D; BRADBURY R; COPOLOV D; DEAN B
    CLOZAPINE AND OLANZAPINE TREATMENT DECREASES RAT CORTICAL AND LIMBIC GABA(A) RECEPTORS
    European journal of pharmacology
    
    D. Farnbachpralong et al., "CLOZAPINE AND OLANZAPINE TREATMENT DECREASES RAT CORTICAL AND LIMBIC GABA(A) RECEPTORS", European journal of pharmacology, 349(2-3), 1998, pp. 7-8
31. BELL R; MCLAREN A; GALANOS J; COPOLOV D
    THE CLINICAL USE OF PLASMA CLOZAPINE LEVELS
    Australian and New Zealand Journal of Psychiatry
    
    R. Bell et al., "THE CLINICAL USE OF PLASMA CLOZAPINE LEVELS", Australian and New Zealand Journal of Psychiatry, 32(4), 1998, pp. 567-574
32. CROOK JM; TOMASKOVIC EM; DEAN B; COPOLOV D
    A POSSIBLE MUSCARINIC INVOLVEMENT IN SCHIZOPHRENIA - REDUCED M(1) RECEPTOR MEASUREMENT IN HUMAN HIPPOCAMPUS
    Schizophrenia research
    
    J.M. Crook et al., "A POSSIBLE MUSCARINIC INVOLVEMENT IN SCHIZOPHRENIA - REDUCED M(1) RECEPTOR MEASUREMENT IN HUMAN HIPPOCAMPUS", Schizophrenia research, 24(1-2), 1997, pp. 32-33
33. COPOLOV D; CROOK J; OPESKIN K; HILL C; KEKS N; DEAN B
    MUSCARINIC M(1) RECEPTORS IN THE CAUDATE-PUTAMEN OF PATIENTS WITH SCHIZOPHRENIA - DECREASED RECEPTOR DENSITY IS NOT ACCOMPANIED BY DECREASED RECEPTOR MESSENGER-RNA
    Schizophrenia research
    
    D. Copolov et al., "MUSCARINIC M(1) RECEPTORS IN THE CAUDATE-PUTAMEN OF PATIENTS WITH SCHIZOPHRENIA - DECREASED RECEPTOR DENSITY IS NOT ACCOMPANIED BY DECREASED RECEPTOR MESSENGER-RNA", Schizophrenia research, 24(1-2), 1997, pp. 32-32
34. KEKS NA; HILL C; ROBERTS S; DEAN B; OPESKIN K; MACKINNON A; COPOLOV D
    DIAGNOSTIC INSTRUMENT FOR BRAIN STUDIES (DIBS)
    Schizophrenia research
    
    N.A. Keks et al., "DIAGNOSTIC INSTRUMENT FOR BRAIN STUDIES (DIBS)", Schizophrenia research, 24(1-2), 1997, pp. 34-34
35. COPOLOV D; HEADLAM D; MACKINNON A; MCKAY C; THOMAS R
    RECENT HALLUCINATORS DEMONSTRATE ABNORMALITIES OF CENTRAL AUDITORY PROCESSING
    Schizophrenia research
    
    D. Copolov et al., "RECENT HALLUCINATORS DEMONSTRATE ABNORMALITIES OF CENTRAL AUDITORY PROCESSING", Schizophrenia research, 24(1-2), 1997, pp. 100-100
36. MARZELLA PL; COPOLOV D
    [H-3] NEMONAPRIDE BINDING IN HUMAN CAUDATE AND PUTAMEN
    Brain research bulletin
    
    P.L. Marzella e D. Copolov, "[H-3] NEMONAPRIDE BINDING IN HUMAN CAUDATE AND PUTAMEN", Brain research bulletin, 44(2), 1997, pp. 167-170
37. CROOK JM; TOMASKOVIC E; PAVEY G; DEAN B; COPOLOV D
    METHODOLOGICAL CONSIDERATIONS FOR M-1 RECEPTOR ANALYSIS AND THE SUBSEQUENT MEASUREMENT OF REDUCED M-1 RECEPTOR DENSITY IN SCHIZOPHRENIA
    Journal of neurochemistry
    
    J.M. Crook et al., "METHODOLOGICAL CONSIDERATIONS FOR M-1 RECEPTOR ANALYSIS AND THE SUBSEQUENT MEASUREMENT OF REDUCED M-1 RECEPTOR DENSITY IN SCHIZOPHRENIA", Journal of neurochemistry, 69, 1997, pp. 247-247
38. MARZELLA PL; HILL C; KEKS N; SINGH R; COPOLOV D
    THE BINDING OF BOTH [H-3] NEMONAPRIDE AND [H-3] RACLOPRIDE IS INCREASED IN SCHIZOPHRENIA
    Biological psychiatry
    
    P.L. Marzella et al., "THE BINDING OF BOTH [H-3] NEMONAPRIDE AND [H-3] RACLOPRIDE IS INCREASED IN SCHIZOPHRENIA", Biological psychiatry, 42(8), 1997, pp. 648-654
39. SMITH D; PANTELIS C; MCGRATH J; TANGAS C; COPOLOV D
    OCULAR ABNORMALITIES IN CHRONIC-SCHIZOPHRENIA - CLINICAL IMPLICATIONS
    Australian and New Zealand Journal of Psychiatry
    
    D. Smith et al., "OCULAR ABNORMALITIES IN CHRONIC-SCHIZOPHRENIA - CLINICAL IMPLICATIONS", Australian and New Zealand Journal of Psychiatry, 31(2), 1997, pp. 252-256
40. COPOLOV D
    NEW NAME FOR ATYPICAL ANTIPSYCHOTICS
    The American journal of psychiatry
    
    D. Copolov, "NEW NAME FOR ATYPICAL ANTIPSYCHOTICS", The American journal of psychiatry, 154(3), 1997, pp. 439-439
41. COPOLOV D
    DIAGNOSIS AND PHENOMENOLOGY OF SCHIZOPHRENIA AND RELATED DISORDERS
    Current opinion in psychiatry
    
    D. Copolov, "DIAGNOSIS AND PHENOMENOLOGY OF SCHIZOPHRENIA AND RELATED DISORDERS", Current opinion in psychiatry, 9(1), 1996, pp. 63-67
42. OPESKIN K; DEAN B; PAVEY G; HILL C; KEKS N; COPOLOV D
    NEITHER PROTEIN-KINASE-C NOR ADENYLATE-CYCLASE ARE ALTERED IN THE STRIATUM FROM SUBJECTS WITH SCHIZOPHRENIA
    Schizophrenia research
    
    K. Opeskin et al., "NEITHER PROTEIN-KINASE-C NOR ADENYLATE-CYCLASE ARE ALTERED IN THE STRIATUM FROM SUBJECTS WITH SCHIZOPHRENIA", Schizophrenia research, 22(2), 1996, pp. 159-164
43. KULKARNI J; DECASTELLA A; SMITH D; TAFFE J; KEKS N; COPOLOV D
    A CLINICAL-TRIAL OF THE EFFECTS OF ESTROGEN IN ACUTELY PSYCHOTIC WOMEN
    Schizophrenia research
    
    J. Kulkarni et al., "A CLINICAL-TRIAL OF THE EFFECTS OF ESTROGEN IN ACUTELY PSYCHOTIC WOMEN", Schizophrenia research, 20(3), 1996, pp. 247-252
44. BREWER WJ; SMITH DJ; VELAKOULIS D; ANDERSON V; MCGORRY P; COPOLOV D; SINGH B; PANTELIS C
    OLFACTORY AND NEUROPSYCHOLOGICAL DEFICITS IN FIRST EPISODE PSYCHOSIS
    Schizophrenia research
    
    W.J. Brewer et al., "OLFACTORY AND NEUROPSYCHOLOGICAL DEFICITS IN FIRST EPISODE PSYCHOSIS", Schizophrenia research, 18(2-3), 1996, p.
45. ROBERTS S; HILL C; DEAN B; KEKS N; OPESKIN K; COPOLOV D
    THE POSTMORTEM DIAGNOSIS OF SCHIZOPHRENIA - SOME PSYCHOSOCIAL AND CLINICAL IMPLICATIONS
    Schizophrenia research
    
    S. Roberts et al., "THE POSTMORTEM DIAGNOSIS OF SCHIZOPHRENIA - SOME PSYCHOSOCIAL AND CLINICAL IMPLICATIONS", Schizophrenia research, 18(2-3), 1996, pp. 1-1
46. VELAKOULIS D; PANTELIS C; COOK MJ; MURRIE V; DESMOND PM; TRESS BM; BREWER WJ; SINGH B; COPOLOV D
    BILATERAL HIPPOCAMPAL VOLUME REDUCTION IN CHRONIC-SCHIZOPHRENIA ON MRI VOLUMETRIC-ANALYSIS
    Schizophrenia research
    
    D. Velakoulis et al., "BILATERAL HIPPOCAMPAL VOLUME REDUCTION IN CHRONIC-SCHIZOPHRENIA ON MRI VOLUMETRIC-ANALYSIS", Schizophrenia research, 18(2-3), 1996, pp. 186-186
47. NAYLOR L; DEAN B; OPESKIN K; PAVEY G; HILL C; KEKS N; COPOLOV D
    CHANGES IN THE SEROTONIN TRANSPORTER IN THE HIPPOCAMPUS OF SUBJECTS WITH SCHIZOPHRENIA IDENTIFIED USING [H-3] PAROXETINE
    Journal of neural transmission
    
    L. Naylor et al., "CHANGES IN THE SEROTONIN TRANSPORTER IN THE HIPPOCAMPUS OF SUBJECTS WITH SCHIZOPHRENIA IDENTIFIED USING [H-3] PAROXETINE", Journal of neural transmission, 103(6), 1996, pp. 749-757
48. HILL C; KEKS N; ROBERTS S; OPESKIN K; DEAN B; MACKINNON A; COPOLOV D
    PROBLEM OF DIAGNOSIS IN POSTMORTEM BRAIN STUDIES OF SCHIZOPHRENIA
    The American journal of psychiatry
    
    C. Hill et al., "PROBLEM OF DIAGNOSIS IN POSTMORTEM BRAIN STUDIES OF SCHIZOPHRENIA", The American journal of psychiatry, 153(4), 1996, pp. 533-537
49. COPOLOV D; CARTER D
    THE MENTAL-HEALTH-RESEARCH-INSTITUTE UNUSUAL PERCEPTIONS SCHEDULE (MUPS)
    Schizophrenia research
    
    D. Copolov e D. Carter, "THE MENTAL-HEALTH-RESEARCH-INSTITUTE UNUSUAL PERCEPTIONS SCHEDULE (MUPS)", Schizophrenia research, 15(1-2), 1995, pp. 8-9
50. DEAN B; OPESKIN K; NAYLOR L; PAVEY G; HILL C; COPOLOV D; KEKS N
    ALTERED HIPPOCAMPAL [H-3] PAROXETINE BINDING IN SUBJECTS WITH SCHIZOPHRENIA
    Schizophrenia research
    
    B. Dean et al., "ALTERED HIPPOCAMPAL [H-3] PAROXETINE BINDING IN SUBJECTS WITH SCHIZOPHRENIA", Schizophrenia research, 15(1-2), 1995, pp. 56-56
51. COPOLOV D; LEE D; HUANG W; LIM A
    D2 RECEPTOR-MEDIATED SUPPRESSION OF IRANF SECRETION FROM HYPOTHALAMICNEURONS DOES NOT INVOLVE TYPE-II ADENYLYL CYCLASES
    Schizophrenia research
    
    D. Copolov et al., "D2 RECEPTOR-MEDIATED SUPPRESSION OF IRANF SECRETION FROM HYPOTHALAMICNEURONS DOES NOT INVOLVE TYPE-II ADENYLYL CYCLASES", Schizophrenia research, 15(1-2), 1995, pp. 64-65
52. LAMBERT T; KEKS N; MCGRATH J; CATTS S; HUSTIG H; VADDADI K; BURROWS G; VARGHESE F; GEORGE T; KERR K; JOHNSON G; BURNETT P; ZORBAS A; HILL C; COPOLOV D
    REMOXIPRIDE VERSUS THIORIDAZINE IN THE TREATMENT OF FIRST EPISODES OFSCHIZOPHRENIA IN DRUG-NAIVE PATIENTS - A CASE FOR SPECIFIC, LOW POTENCY D-2 ANTAGONISTS
    Human psychopharmacology
    
    T. Lambert et al., "REMOXIPRIDE VERSUS THIORIDAZINE IN THE TREATMENT OF FIRST EPISODES OFSCHIZOPHRENIA IN DRUG-NAIVE PATIENTS - A CASE FOR SPECIFIC, LOW POTENCY D-2 ANTAGONISTS", Human psychopharmacology, 10(6), 1995, pp. 455-460
53. WONG MTH; BREWER W; CARTER D; COPOLOV D
    EPILEPSY AS A DIFFERENTIAL-DIAGNOSIS FOR MULTIMODAL HALLUCINATIONS - A CASE-REPORT
    Epilepsia
    
    M.T.H. Wong et al., "EPILEPSY AS A DIFFERENTIAL-DIAGNOSIS FOR MULTIMODAL HALLUCINATIONS - A CASE-REPORT", Epilepsia, 36, 1995, pp. 177-177
54. SUNDRAM S; DEAN B; COPOLOV D
    DOPAMINE UPTAKE IN PLATELETS - RESPONSE
    Biological psychiatry
    
    S. Sundram et al., "DOPAMINE UPTAKE IN PLATELETS - RESPONSE", Biological psychiatry, 38(6), 1995, pp. 416-417
55. KULKARNI J; DECASTELLA A; SMITH D; MCKENZIE D; KEKS N; SINGH B; COPOLOV D
    GONADOTROPIN-RESPONSE TO NALOXONE CHALLENGE IN FEMALE AND MALE PSYCHOTIC-PATIENTS - A PILOT-STUDY
    Biological psychiatry
    
    J. Kulkarni et al., "GONADOTROPIN-RESPONSE TO NALOXONE CHALLENGE IN FEMALE AND MALE PSYCHOTIC-PATIENTS - A PILOT-STUDY", Biological psychiatry, 38(10), 1995, pp. 701-703
56. KULKARNI J; SMITH D; MCKENZIE D; HILL C; KEKS N; SINGH B; COPOLOV D
    GONADOTROPIN-RESPONSE TO NALOXONE CHALLENGE IN MALE AND FEMALE PSYCHOTIC-PATIENTS
    Schizophrenia research
    
    J. Kulkarni et al., "GONADOTROPIN-RESPONSE TO NALOXONE CHALLENGE IN MALE AND FEMALE PSYCHOTIC-PATIENTS", Schizophrenia research, 11(2), 1994, pp. 129-129
57. MCGORRY PD; MIHALOPOULOS C; HARRIGAN S; MCKENZIE D; HENRY L; DAKIS J; JACKSON H; KULKARNI J; COPOLOV D
    SPURIOUS PRECISION - VARIABILITY IN PROCEDURAL VALIDITY OF DIAGNOSTICMETHODS IN PSYCHOTIC DISORDERS AND IMPLICATIONS FOR RESEARCH AND TREATMENT
    Schizophrenia research
    
    P.D. Mcgorry et al., "SPURIOUS PRECISION - VARIABILITY IN PROCEDURAL VALIDITY OF DIAGNOSTICMETHODS IN PSYCHOTIC DISORDERS AND IMPLICATIONS FOR RESEARCH AND TREATMENT", Schizophrenia research, 11(2), 1994, pp. 182-182
58. KEKS N; MCGRATH J; LAMBERT T; CATTS S; VADDADI K; BURROWS G; VARGHESE F; GEORGE T; HUSTIG H; BURNETT P; KERR K; ZORBAS A; HILL C; STEDMAN T; JOHNSON G; LEIBERT B; COPOLOV D; MACKENZIE M; DILLENBECK C
    THE AUSTRALIAN MULTICENTER DOUBLE-BLIND COMPARATIVE-STUDY OF REMOXIPRIDE AND THIORIDAZINE IN SCHIZOPHRENIA
    Acta psychiatrica Scandinavica
    
    N. Keks et al., "THE AUSTRALIAN MULTICENTER DOUBLE-BLIND COMPARATIVE-STUDY OF REMOXIPRIDE AND THIORIDAZINE IN SCHIZOPHRENIA", Acta psychiatrica Scandinavica, 90(5), 1994, pp. 358-365